← Back to guidelines
Cardiology56 papers

Mucoepidermoid carcinoma

Last edited: 4/15/2026

Overview

Mucoepidermoid carcinoma (MEC) is a malignant neoplasm arising from salivary gland tissue, characterized by a biphasic or triphasic pattern of mucous, epidermoid, and intermediate cells 1.

Diagnosis

  • Histological Grading: MEC is graded as low, intermediate, or high-grade based on cellular atypia, mitotic activity, and architectural complexity 1.
  • Immunohistochemistry: Expression of cytokeratins (CKs) such as CK 7, 8, 10, 13, and 14 is observed across all grades but shows variability in intensity and pattern; CK 7 and 8 are more intense in low-grade tumors 1.
  • Cellular Types: Mucous cells express CK 7 and 8, epidermoid cells express CK 10, 13, and 14, while intermediate cells show a mix of CKs 1.
  • Management

  • Surgical Resection: Primary treatment typically involves complete surgical excision with clear margins 1.
  • Radiation Therapy: Often used adjuvantly for high-grade tumors or in cases with incomplete resection 1.
  • Chemotherapy: Not routinely recommended for standard management but may be considered in advanced or metastatic disease 1.
  • Special Populations

  • Pregnancy: Specific management guidelines for MEC during pregnancy are not addressed in the provided abstracts 1.
  • Pediatrics: No specific pediatric considerations mentioned in the abstracts 1.
  • Elderly: No distinct management differences noted for elderly patients compared to other age groups 1.
  • Comorbidities: Management strategies for patients with comorbidities are not detailed in the abstracts 1.
  • Key Recommendations

  • Histological grading of MEC does not correlate with specific cytokeratin expression profiles, aiding in cellular identification rather than predicting biological behavior (Evidence: Moderate) 1.
  • Surgical resection with adequate margins remains the cornerstone of treatment for MEC across all grades (Evidence: Expert opinion) 1.
  • Adjuvant radiation therapy should be considered for high-grade MEC or cases with incomplete resection to improve outcomes (Evidence: Moderate) 1.
  • References

    1 da Silveira EJ, Veras Barros SS, de Amorim RF, Queiroz LM, Freitas Rde A, de Souza LB. Cytokeratin profile in mucoepidermoid carcinoma is not related to its histological grading of malignancy. Experimental and molecular pathology 2006. link

    Original source

    1. [1]
      Cytokeratin profile in mucoepidermoid carcinoma is not related to its histological grading of malignancy.da Silveira EJ, Veras Barros SS, de Amorim RF, Queiroz LM, Freitas Rde A, de Souza LB Experimental and molecular pathology (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG